Chief Scientist and co-founder of CellGevity, Inc., Dr. Nagasawa
received his B.S. degree in chemistry from Western Reserve University (now,
Case-Western Reserve) in Cleveland, Ohio, and the Ph.D. degree in organic
chemistry from the University of Minnesota. Subsequently, he spent two years as
a Post-doctoral Fellow in biochemistry at the University of Minnesota before
joining the research staff of the V.A. Medical Center in Minneapolis as a
Senior Chemist. He was appointed Assistant Professor of Medicinal Chemistry at
the University of Minnesota in 1959. He was named Principal Scientist of the
VAMC in 1961 and was promoted in 1976 to Senior Research Career Scientist, a
nationwide VA title reserved for the VA's top scientists. He was promoted to
Associate Professor in 1963 and to Professor of Medicinal Chemistry in 1973. He
also held joint professorships in the Department of Pharmacology and the
university-wide Division of Toxicology, and served as Visiting Professor at
Washington State University in 1990. He also served for 32 years as a Senior
Editor for the prestigious international Journal of Medicinal Chemistry from
1972 to 2004, and one year as Acting Editor-in-Chief. In addition, he served on
the Editorial Board of the journal, Bioconjugate Chemistry for eight years, and
as an ad hoc grant reviewer for the NCI and NIAAA, National Institutes of
Health. He has published over 165 papers in peer-reviewed journals, and is the
inventor named on ten U.S. and PCT patent applications.
Dr. Keller has served on the scientific review panels for the
National Institutes of Health and the VA. The Consumers' Research Council has
named him one of America's "Top Physicians in 2003, 2004, 2005, 2006, and
2007 in the fields of Internal Medicine, Immunology and Hematology." Dr.
Keller has served on the faculties of the Mayo Graduate School of Medicine, the
University of Wisconsin and the Medical College of Wisconsin (Marquette Univ.)
He has published more than 100 original articles in various scientific and
medical journals and has been awarded several patents. Dr. Keller was elected
to The Board of Governors of the American Academy of HIV Medicine.
No comments:
Post a Comment